线粒体单倍群影响糖尿病视网膜病变的严重程度但不影响其患病率
研究纳入来自BioVU的637例高加索裔糖尿病患者(223例有糖尿病视网膜病变)和来自Vanderbilt眼科研究所的197例高加索裔糖尿病患者(98例有糖尿病视网膜病变),检验欧洲线粒体单倍群与糖尿病视网膜病变状态的关联。结果显示,糖尿病视网膜病变的患病率在各单倍群间无差异(P=0.32),但非增殖性糖尿病视网膜病变(P=0.0084)和增殖性糖尿病视网膜病变(P=0.027)的百分比在各单倍群间存在显著差异。结论认为线粒体单倍群H和UK与糖尿病视网膜病变的严重程度相关,但与其是否存在无关。
要点
- 糖尿病视网膜病变患病率在各线粒体单倍群间无差异(P=0.32)。
- 非增殖性和增殖性糖尿病视网膜病变的百分比在各单倍群间存在显著差异。
- 调整混杂因素后,单倍群H和UK对糖尿病视网膜病变无显著影响。
核心结论
- 线粒体单倍群H和UK与糖尿病视网膜病变的严重程度相关,但与其是否存在无关。
- 这些数据提示这些单倍群的效应与缺血和新生血管形成有关,而这是增殖性糖尿病视网膜病变的定义性特征。
研究设计与样本
- 研究从BioVU(Vanderbilt大学电子去标识DNA数据库)获取637例高加索裔糖尿病患者的去标识医疗记录,其中223例有糖尿病视网膜病变。
- 另从Vanderbilt眼科研究所(VEI)入组197例高加索裔糖尿病患者,其中98例有糖尿病视网膜病变。
- 研究检验欧洲线粒体单倍群与糖尿病视网膜病变状态之间的关联。
主要发现
- 糖尿病视网膜病变患者在单倍群间的百分比无差异(P=0.32)。
- 非增殖性糖尿病视网膜病变患者的百分比在各单倍群间显著不同(P=0.0084)。
- 增殖性糖尿病视网膜病变患者的百分比在各单倍群间显著不同(P=0.027)。
- 在调整性别、年龄、糖尿病类型、糖尿病病程和糖化血红蛋白的logistic回归中,与糖尿病对照相比,单倍群H和单倍群UK对糖尿病视网膜病变均无显著影响。
- 与非增殖性糖尿病视网膜病变相比,在未调整分析中单倍群UK是显著的危险因素(OR=1.72 [1.13-2.59],P=0.010),但在调整分析中不显著(OR=1.29 [0.79-2.10],P=0.20)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We previously reported European mitochondrial haplogroup H to be a risk factor for and haplogroup UK to be protective against proliferative diabetic retinopathy (PDR) among Caucasian patients with diabetic retinopathy (DR). The purpose of this study was to determine whether these haplogroups are also associated with the risk of having DR among Caucasian patients with diabetes. METHODS: Deidentified medical records for 637 Caucasian patients with diabetes (223 with DR) were obtained from BioVU, Vanderbilt University's electronic, deidentified DNA databank. An additional 197 Caucasian patients with diabetes (98 with DR) were enrolled from the Vanderbilt Eye Institute (VEI). We tested for an association between European mitochondrial haplogroups and DR status. RESULTS: The percentage of diabetes patients with DR did not differ across the haplogroups (P = 0.32). The percentage of patients with nonproliferative DR (NPDR; P = 0.0084) and with PDR (P = 0.027) significantly differed across the haplogroups. In logistic regressions adjusting for sex, age, diabetes type, duration of diabetes, and hemoglobin A1c, neither haplogroup H nor haplogroup UK had a significant effect on DR compared with diabetic controls. Haplogroup UK was a significant risk factor (OR = 1.72 [1.13-2.59], P = 0.010) for NPDR compared with diabetic controls in the unadjusted analysis, but not in the adjusted analysis (OR = 1.29 [0.79-2.10], P = 0.20). CONCLUSIONS: Mitochondrial haplogroups H and UK were associated with severity, but not presence, of DR. These data argue that the effect of these haplogroups is related to ischemia and neovascularization, the defining features of PDR.
引用
- Bregman JA, Herren DJ, Estopinal CB, et al. Mitochondrial Haplogroups Affect Severity But Not Prevalence of Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017. PMID: 28245487. doi:10.1167/iovs.16-20616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。